Clinical Trial Detail

NCT ID NCT00902044
Title Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Baylor College of Medicine
Indications

sarcoma

osteosarcoma

Therapies

Fludarabine

Cyclophosphamide

HER2 sensitized T-cells

Age Groups: adult

Additional content available in CKB BOOST